Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Idenix Pharmaceuticals has named Ronald Renaud as the new president, CEO and a member of the board of directors of the company.
Subscribe to our email newsletter
Before joining Idenix in 2007, Renaud worked as the senior vice president and chief financial officer of Keryx Biopharmaceuticals.
Idenix Pharma lead director of the board of directors Thomas Hodgson said that Jean-Pierre has guided development of Idenix since inception and the company has made considerable progress under his leadership.
"We are extremely pleased to have Ron Renaud, an experienced and capable executive who has worked closely with the board of directors, move into the position of President and CEO," Hodgson said.
Idenix Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases.